Activation of adhesion molecules in patients with septic shock;Activation des molécules d'adhésion chez les patients en choc septique

Annales Francaises d'Anesthesie et de Reanimation

Volumn 22, Issue 8, 2003, Pages 721-729

  Leone, M ^a   Garcin, F ^a   Chaabane, W ^a   Boutiere Albanese B ^b   Albanese J ^b   Dignat Georges, F ^b   Martin, C ^a  

^a HÔPITAL NORD   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Adhesion molecule; Inflammation; Integrins; Selectins; Septic shock

Indexed keywords

BIMOSIAMOSE; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; L SELECTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY EP5C7; NITRIC OXIDE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PEPTIDE DERIVATIVE; RECOMBINANT SOLUBLE P SELECTIN GLYCOPROTEIN LIGAND 1; SELECTIN; SELECTIN ANTAGONIST; TBC 1268; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

BLOOD LEVEL; DRUG EFFECT; HUMAN; HYPOXIA; INFLAMMATION; LEUKOCYTE MIGRATION; PROTEIN EXPRESSION; REVIEW; SEPTIC SHOCK; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

EID: 0142075716     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(03)00327-7     Document Type: Short Survey

References (82)

1. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Steams-Kurosawa DJ, et al. Inflammation, sepsis, and coagulation. Haematologica 1999;84:254-9.
2. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.
3. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989;243:1160-5.
4. Bochner BS, Luscinskas FW, Gimbrone MA, Newman W, Sterbinsky SA, Derse-Anthony CP, et al. Adhesion of humans' basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: Contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-7.
5. Engelberts I, Samyo SK, Leeuwenberg JF, van der Linden CJ, Buurman WA. A role for ELAM-1 in the pathogenesis of MOF during septic shock. J Surg Res 1992;53:136-44.
6. Johnston GI, Cook RG, McEver RP. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989;56:1033-44.
7. Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990;343:757-60.
8. Munoz FM, Hawkins EP, Bullard DC, Beaudet AL, Kaplan SL. Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice. J Clin Invest 1997;100:2099-106.
9. Jung U, Ley K. Mice lacking two or all three selectins demonstrates overlapping and distinct functions for each selectin. J Immunol 1999;162:6755-62.
10. Yang J, Hirata T, Croce K, Merrill-Skoloff G, Tchernychev B, Williams E, et al. Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J Exp Med 1999;190:1769-82.
11. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000;97:13835-40.
12. Eppihimer MJ, Russell J, Langley R, Gerritsen M, Granger DN. Role of tumor necrosis factor and interferon gamma in endotoxin-induced E-selectin expression. Shock 1999;11:93-7.
13. Kunkel EJ, Ley K. Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ Res 1996;79:1196-204.
14. Homeister JW, Zhang M, Frenette PS, Hynes RO, Wagner DD, Lowe JB, et al. Overlapping functions of E- and P-selectin in neutrophil recruitment during acute inflammation. Blood 1998;92:2345-52.
15. Bullard DC, Kunkel EJ, Kubo H, Hicks MJ, Lorenzo I, Doyle NA, et al. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med 1996;183:2329-36.
16. Vestweber D, Blanks JE. Mechanisms that regulate the function of the selecti ns and their ligands. Physiol Rev 1999;79:181-213.
17. Ley K, Gaehtgens P, Fennie C, Singer MS, Lasky LA, Rosen SD. Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 1991;77:2553-5.
18. Crockett-Tobari E, Fantone JC. L-selectin stimulation of canine neutrophil initiates calcium signal secondary to tyrosine kinase activation. Am J Physiol 1997;272(3Pt2):H1302-8.
19. Hickey MJ, Forster M, Mitchell D, Kaur J, De Caigny C, Kubes P. L-selectin facilitates emigration and extravascular locomotion of leukocytes during acute inflammatory responses in vivo. J Immunol 2000;165:7164-70.
20. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-61.
21. Sligh Jr JE, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A, et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1993;90:8529-33.
22. Steeber DA, Campbell MA, Basit A, Ley K, Tedder TF. Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc Natl Acad Sci USA 1998;95:7562-7.
23. Konstantopoulos K, Kukreti S, McIntire LV. Biomechanics of cell interactions in shear fields. Adv Drug Deliv Rev 1998;33:141-64.
24. Steeber DA, Tang ML, Green NE, Zhang XQ, Sloane JE, Tedder TF. Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. J Immunol 1999;163:2176-86.
25. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA 1999;96:9815-20.
26. Anfosso F, Bardin N, Vivier E, Sabatier F, Sampol J, Dignat-George F. Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J Biol Chem 2001;276:1564-9.
27. Bardin N, Anfosso F, Massé JM, Cramer E, Sabatier F, Le Bivic A, et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 2001;98:3677-84.
28. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 1997;29:159-66.
29. Nankervis CA, Miller CE. Developmental differences in response of mesenteric artery to acute hypoxia in vitro. Am J Physiol 1998;274: G694-9.
30. Ten VS, Pinsky DJ. Endothelial response to hypoxia: Physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 2002;8:242-50.
31. Lush CW, Cepinskas G, Sibbald WJ, Kvietys PR. Endothelial E- and P-selectin expression in iNOS-deficient mice exposed to polymicrobial sepsis. Am J Physiol Gastro-intest Liver Physiol 2001;280: G291-7.
32. Benjamim CF, Silva JS, Fortes ZB, Oliveira MA, Ferreira SH, Cunha FQ. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduce migration of active microbicidal neutrophils. Infect Immun 2002;70:3602-10.
33. Closse C, Seigneur M, Renard M, Pruvost A, Dumain P, Belloc F, et al. Influence of hypoxia and hypoxia-reoxygenation on endothelial P-selectin expression. Thromb Res 1997;85:159-64.
34. Zund G, Nelson DP, Neufeld EJ, Dzus AL, Bischoff J, Mayer JE, et al. Hypoxia enhances stimulus-dependent induction of E-selectin on aortic endothelial cells. Proc Natl Acad Sci USA 1996;93:7075-80.
35. Kokura S, Rhoads CA, Wolf RE, Yoshikawa T, Granger DN, Aw TY. NF kappa b signaling in posthypoxic endothelial cells: Relevance to E-selectin expression and neutrophil adhesion. J Vasc Res 2001;38:47-58.
36. Willam C, Schindler R, Frei U, Eckardt KU. Increases in oxygen tension stimulate expression of ICAM-1 and VCAM-1 on human endothelial cells. Am J Physiol 1999;276:H2044-52.
37. Leone M, Boutière B, Camoin-Jau L, Albanèse J, Horschowsky N, Mège JL, et al. Systemic endothelial activation is greater in septic than in traumatic-hemorrhagic shock but does not correlate with endothelial activation in skin biopsies. Crit Care Med 2002;30:808-14.
38. Engelberts I, Samyo SK, Leeuwenberg JF, van der Linden CJ, Buurman WA. A role for ELAM-1 in the pathogenesis of MOF during septic shock. J Surg Res 1992;53:136-44.
39. Boldt J, Müller M, Khun D, Linke LC, Hempelmann G. Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med 1996;22:122-8.
40. Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998;157:776-84.
41. Weygand MA, Schmidt H, Pourmahnoud M, Zhao Q, Martin E, Bardenheur HJ. Circulating intercellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock. Crit Care Med 1999;27:2656-61.
42. Sessler CN, Windsor AC, Schwartz M, Watson L, Fisher BJ, Sugerman HJ, et al. Circulating 1CAM-1 is increased in septic shock. Am J Respir Crit Care Med 1995;151:1420-7.
43. Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler 3rd AA. Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 1997;156:431-7.
44. Soderquist B, Sundqvist KG, Vikerfors T. Adhesion molecules (E-selectin, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1)) in sera from patients with Staphylococcus aureus bacteraemia with or without endocarditis. Clin Exp Immunol 1999;118:408-11.
45. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993;150:644-54.
46. Knapp S, Thalhammer F, Locker GJ, Laczika K, Hollenstein U, Frass M, et al. Prognostic value of MIP-1 alpha, TGF-beta 2, sELAM-1, and sVCAM-1 in patients with gram-positive sepsis. Clin Immunol Immunopath 1998;87:139-44.
47. Cowley HC, Heney D, Gearing AJ, Hemingway I, Webster NR. Increased circulating adhesion molecule concentrations in patients with systemic inflammatory response syndrome: a prospective study. Crit Care Med 1994;22:651-7.
48. Turner GD, Ly VC, Nguyen TH, Tran TH, Nguyen HP, Bethell D, et al. Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol 1998;152:1477-87.
49. Redl H, Dinges HP, Buurman WA, van der Linden CJ, Pober JS, Cotran RS, et al. Expression of endothelial leukocyte adhesion molecule-1 in septic but not traumatic-hypovolemic shock in the baboon. Am J Pathol 1991;139:461-6.
50. Sakamaki F, Ishizaka A, Handa M, Fujishima S, Urano T, Sayama K, et al. Soluble form of P-selectin is elevated in acute lung injury. Am J Respir Crit Care Med 1995;151:1821-6.
51. Ley K, Bullard DC, Arbones ML, Bosse R, Vestweber D, Tedder TF, et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med 1995;181:669-75.
52. Scalia R, Armstead VE, Minchenko AG, Lefer AM. Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J Exp Med 1999;189:931-8.
53. Simons RK, Hoyt DB, Winchell RJ, Rose RM, Holbrook T. Elevated selectin levels after severe trauma: a marker for sepsis and organ failure and a potential target for immunomodulatory therapy. J Trauma 1996;41:653-62.
54. Leone M, Boutière-Albanèse B, Delmas A, Camoin-Jau L, Dignat-George F, Martin C. Évaluation du CD146 lors du choc septique, du sepsis sévère et du choc traumatique. Ann Fr Anesth Réanim 2002; 21 (Suppl 2):R180.
55. Boehme MW, Werle E, Kommerell B, Raeth U. Serum levels of adhesion molecules and thrombomodulin as indicators of vascular injury in severe Plasmodium falciparum malaria. Clin Investig 1994;72:598-603.
56. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:4220-4.
57. Komatsu S, Flores S, Gerritsen ME, Anderson DC, Granger DN. Differential up-regulation of circulating soluble and endothelial cell intercellular adhesion molecule-1 in mice. Am J Pathol 1997;151:205-14.
58. McGill SN, Ahmed NA, Hu F, Michel RP, Christou NV. Shedding of L-selectin as a mechanism for reduced polymorphonuclear neutrophil exudation in patients with systemic inflammatory response syndrome. Arch Surg 1996;131:1141-7.
59. Jones SC, Banks RE, Haidar A, Gearing AJ, Hemingway IK, Ibbotson SH, et al. Adhesion molecules in inflammatory bowel disease. Gut 1995;36:724-30.
60. Leclerc J, Pu Q, Corseaux D, Haddad E, Decoene C, Bordet R, et al. A single endotoxin injection in the rabbit causes prolonged blood vessel dysfunction and a procoagulant state. Crit Care Med 2000;28:3672-8.
61. Paret G, Prince T, Keller N, Dagan O, Sasson Y, Barzilai A, et al. Plasma-soluble E-selectin after cardiopulmonary bypass in children: is it a marker of the postoperative course? J Cardiothorac Vasc Anesth 2000;14:433-7.
62. Endo S, Inada K, Kasai T, Takakuwa T, Yamada Y, Koike S, et al. Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. J Inflamm 1995;46:212-9.
63. Hynninen M, Valtonen M, Markkanen H, Vaara M, Kuusela P, Jousela I, et al. Interleukin 1 receptor antagonist and E-selectin concentrations: a comparison in patients with severe acute pancreatitis and severe sepsis. J Crit Care 1999;14:63-8.
64. Harlan JM, Winn RK. Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit Care Med 2002;30(Suppl): S214-9.
65. Briggs JB, Oda Y, Gilbert JH, Schaefer ME, Macher BA. Peptides inhibit selectin-mediated cell adhesion in vitro, and neutrophil influx into inflammatory sites in vivo. Glycobiology 1995;5:583-8.
66. Mulligan MS, Varani J, Dame MK, Lane CL, Smith CW, Anderson DC, et al. Role of endothelial-leukocyte adhesion molecule-1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest 1991;88:1396-406.
67. Horgan MJ, Ge M. Gu J, Rothlein R, Malik AB. Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion. Am J Physiol 1991;261:H1578-84.
68. Mulligan MS, Miyasaka M, Ward PA. Protective effects of combined adhesion molecule blockade in models of acute lung injury. Proc Assoc Am Physicians 1996;108:198-208.
69. Singbarti K, Ley K. Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin. Crit Care Med 2000;28:2507-14.
70. Nemoto T, Burne MJ, Daniels F, O'Donnell MP, Crosson J, Berens K, et al. Small molecule selectin ligand improves outcome in ischemic acute renal failure. Kidney Int 2001;60:2205-14.
71. Anaya-Prado R, Ramos-Kelly JR, Toledo-Pereyra LH, Walsh J, Ward PA. Multiple selectin blockade with a small-molecule selectin inhibitor does not affect survival after a second inflammatory challenge with nonlethal LPS. J Invest Surg 2002;15:171-80.
72. Sun X, Rozenfeld RA, Qu X, Huang W, Gonzalez-Crussi F, Hsueh W. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. Am J Physiol 1997;273:G56-61.
73. Scalia R, Hayward R, Armstead VE, Minchenko AG, Lefer AM. Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte-endothelium interaction in vivo. Role in rat traumatic shock. Circ Res 1999;84:93-102.
74. Bienvenu JG, Tanguay JF, Theoret JF, Kumatr A, Schaub RG, Merhi Y. Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation 2001;103:1128-34.
75. Kyriakides C, Austen Jr W, Wang Y, Favuzza J, Moore Jr FD, Hechtman HB. Endothelial selectin blockade attenuates lung permeability of experimental acid aspiration. Surgery 2000;128:327-31.
76. Mocco, Choudhri T, Huang J, Harfeldt E, Efros L, Klingbeil C, et al. HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circ Res 2002;91:907-14.
77. Schlag G, Redl HR, Till GO, Davies J, Martin U, Dumont L. Anti-L-selectin antibody treatment of hemorrhagic-traumatic shock in baboons. Crit Care Med 1999;27:1900-7.
78. Rhee P, Morris J, Dhuram R, Hauser C, Cipolle M, Wilson R, et al. Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: results of a phase II clinical trial. Traumatic Shock Group. J Trauma 2000;49:611-9.
79. Baran KW, Nguyen M, McKendall GR, Lambrew CT, Dykstra G, Palmeri ST, et al. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation 2001;104:2778-83.
80. Dove A. CD18 trials disappoint against. Nat Biotechnol 2000;18:817-8.
81. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50.
82. Lin E, Calvano SE, Lowry SF. Selectin neutralization: Does it make biological sense? Crit Care Med 1999;27:2050-3.